JPMorgan Reiterates Neutral Rating on Biogen (BIIB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 247.05 +6.07 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.98 | 52 Week High | $333.65 | |||
| Open | $240.61 | 52 Week Low | $223.02 | |||
| Day High | $247.20 | P/E | 31.63 | |||
| Day Low | $240.02 | EPS | $7.81 | |||
| Volume | 107,697 | |||||
